Initial Hearing Scheduled in Federal Actos Bladder Cancer Litigation

FOR IMMEDIATE RELEASE
Los Angeles, California, United States of America (Free-Press-Release.com) February 14, 2012 -- Los Angeles, CA, February 14, 2012 – The Honorable Judge Rebecca Doherty issued an order on Monday announcing that she would be appointing lead counsel for the consolidated Actos lawsuits following a March 22nd status conference set to take place in Lafayette, LA. Judge Doherty was assigned to oversee the proceedings after the U.S. Judicial Panel on Multidistrict Litigation voted to centralize all federal Actos lawsuits in the Western District of Louisiana in December 2011.

The plaintiffs in the lawsuits allege that Actos (pioglitazone) caused them to develop serious side effects, including bladder cancer. The litigants also claim that the drug’s manufacturer, Takeda Pharmaceuticals, knew of the potential bladder cancer risk but failed to adequately warn consumers of the possible dangers.

The lawsuits against Takeda and co-defendant Eli Lilly began mounting following a June 2011 safety communication issued by the U.S. Food and Drug Administration. In their announcement, the FDA warned that patients who used Actos for a year or more were at an elevated risk of developing bladder cancer. Following the announcement, sales of Actos have declined slightly but the drug remains a popular treatment alternative for adult patients with Type 2 diabetes.

Reportedly, the number of lawsuits filed against Takeda nationwide total less than 200 but that number is expected to grow. A December 2011 Bloomberg article suggested that Takeda could face 10,000 or more lawsuits in connection with patients who suffered Actos side effects.

Patients who were diagnosed with bladder cancer after taking Actos may be eligible to file a claim for compensation. These individuals are encouraged to seek the aid of an experienced personal injury lawyer to discuss their legal rights.

Nadrich & Cohen LLP is offering confidential, no-cost consultations to patients who believe they developed bladder cancer after using Actos. Help is available by calling the firm’s injury hotline at 1-800-718-4658 or by completing an online contact form at www.sideeffectactos.com.

Nadrich & Cohen LLP is a national law firm with offices in Los Angeles, Sacramento, San Diego and other cities throughout California specializing in handling mass tort actions and representing individuals in cases involving pharmaceutical companies and medical device manufacturers. The firm is committed to achieving the best outcome possible in every case and has recovered over $200 million in settlements on behalf of its clients.

In addition to handling Actos side effects claims, the firm is also actively investigating cases involving Yaz, DePuy ASR hips, Zoloft, Fosamax, Paxil, Wright Conserve Hips, Stevens-Johnson Syndrome, Benzene, Reflex Sympathy Dystrophy, Fen Phen and Asbestos exposure. For more information, visit www.personalinjurylawcal.com.

###

Contact:

Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
info@personalinjurylawcal.com

www.personalinjurylawcal.com

Actos     actos attorney     Actos Bladder Cancer     actos class action     Actos Lawsuit     actos lawyer     actos litigation     Actos side effects